These drugs, known as GLP-1 receptor agonists, have ushered in a new era of treatment options that are changing lives and reshaping our approach to weight management and metabolic health
Taking it more frequently would lead to dangerous accumulation
Dr Markku Lhteenvuo, a research director at the University of Eastern Finland, said: It is possible that, in addition to factors such as reduced alcohol consumption, weight loss-related improvements in body image, or relief associated with better glycaemic control in diabetes, there may also be direct neurobiological mechanisms involved, for example, through changes in the functioning of the brains reward system. Responding to the findings, experts urged caution, including Prof David Nutt, who is the head of the neuropsychopharmacology unit at Imperial College London and chair of the independent scientific committee Drug Science
Ann New York Acad Sci (1990) 587:12339